[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H. Res. 1433 Introduced in House (IH)]
111th CONGRESS
2d Session
H. RES. 1433
Expressing support for designation of September 2010 as Blood Cancer
Awareness Month.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 10, 2010
Mr. Jones (for himself, Ms. Markey of Colorado, Mr. Whitfield, and Mr.
Loebsack) submitted the following resolution; which was referred to the
Committee on Energy and Commerce
_______________________________________________________________________
RESOLUTION
Expressing support for designation of September 2010 as Blood Cancer
Awareness Month.
Whereas blood-related cancers currently afflict more than 900,000 people in the
United States, with an estimated 150,000 new cases diagnosed each year;
Whereas leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes, and
myeloproliferative disorders will kill more than 50,000 people in the
United States this year;
Whereas Congress, in the National Cancer Act, established an aggressive Federal
program for the diagnosis, prevention, and treatment of cancer;
Whereas Congress has maintained a steady investment in cancer research to answer
basic questions about the causes of cancer and to develop new treatments
for cancer;
Whereas the Federal investment in cancer research and control has contributed to
important progress in understanding and treating some blood cancers and
yielded significant advances in survival for some forms of blood cancer;
Whereas continued investment and innovation is critical to the early diagnosis
and the more effective and safer treatment for blood cancers where
research and treatment advances have to date been limited;
Whereas strategies to enhance and strengthen the cancer clinical research
program and boost participation in clinical trials are necessary to
achieve blood cancer treatment advances;
Whereas survivors of blood cancer may experience serious late and long-term
effects of their treatment and may need life-long follow-up and
survivorship care;
Whereas Congress has provided strong support to blood cancer research and has
focused special attention on increasing awareness of blood cancers and
intensifying the blood cancer research program;
Whereas the House of Representatives will continue to provide support for
research for a cure for leukemia, lymphoma, multiple myeloma,
myelodysplastic syndromes, and myeloproliferative disorders; and
Whereas September 2010 would be an appropriate month to designate as Blood
Cancer Awareness Month: Now, therefore, be it
Resolved, That the House of Representatives--
(1) supports the designation of Blood Cancer Awareness
Month to enhance the understanding of blood-related cancers,
increase support for funding research to find a cure for blood
cancers, encourage studies of the cause and prevention of blood
cancers to reduce the number of new cases, and enhance
understanding of clinical trials to boost provider and patient
participation and accelerate the pace of clinical research;
(2) encourages participation in voluntary activities to
support blood cancer research and education; and
(3) respectfully requests the Clerk of the House to
transmit a copy of this resolution to the American Society of
Hematology, the International Myeloma Foundation, the Lymphoma
Research Foundation, the Multiple Myeloma Research Foundation,
and The Leukemia & Lymphoma Society voluntary health
organizations dedicated to finding a cure for blood cancers.
<all>